Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sobhan Darou is a leading pharmaceutical manufacturer based in Iran, specializing in the production of high-quality generic medicines. Established in 1976, the company has grown to become a dominant player in the domestic market, particularly within the central nervous system (CNS) and cardiovascular therapeutic areas. Its manufacturing site in the Industrial City of Rasht is one of the most advanced in the region, producing a vast array of tablets, capsules, and topical products. The company is a key subsidiary of the Barakat Pharmaceutical Group, which is one of the largest healthcare conglomerates in the Middle East. Sobhan Darou is publicly traded on the Tehran Stock Exchange and maintains a strong focus on expanding its export portfolio to neighboring countries. The firm is recognized for its adherence to international Good Manufacturing Practice (GMP) standards and its robust research and development efforts in formulation science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sobhan Darou.